Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C
about
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic ManifestationsHepatitis C Virus, Insulin Resistance, and SteatosisPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Mechanisms and significance of liver steatosis in hepatitis C virus infectionInsulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infectionWeight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trialChanges in lipid metabolism in chronic hepatitis C.Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis BFibrosis progression in chronic hepatitis C virus infection.Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.Hepatitis C virus-induced hepatocellular steatosis.Hepatitis C virus infection: Are there still specific problems with genotype 3?Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link.Hepatitis C and steatosis: a reappraisal.Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis CMTP -493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients.Hepatitis C and diabetes: the inevitable coincidence?Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy.Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis.Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis.Hepatic steatosis in chronic hepatitis C: baseline host and viral characteristics and influence on response to therapy with peginterferon alpha-2a plus ribavirin.Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases
P2860
Q26745576-7A5AC2F4-FD6C-4846-B681-643D59C72F39Q26751755-CB69D8FB-14B3-4C61-8C0E-0CFB45E688B4Q26861095-AB526183-78D5-4BDE-8B0E-D66033EC3746Q27478329-59998877-1D29-4A4E-95EC-651C1D1599EEQ30360538-477DAAEF-06E7-4E80-B644-7A6F6FA31F8CQ33866272-58AF0836-F279-4173-956E-372E240ED114Q35098353-1302D80C-A662-4314-9EDA-09C6E74CCB6CQ35142681-19283A60-0947-4AAE-9B12-99034F1E02C5Q35165949-0654BF0A-5392-4E41-8F27-5B653A4412F5Q35555702-91282FB5-7C0F-4BFE-B52E-83412267EA74Q35666213-610860AC-171F-40E8-B74D-43BE32627B1EQ35761351-78220981-B835-4CE9-ABAE-A5289B99A11CQ36060022-52103716-DAD7-40DA-A496-2B74CAADDD9FQ36269670-1395D01C-2A89-43A3-B3B9-6298005ED6B0Q36286323-60675515-FA3B-4057-88B8-E796CD75A176Q36377276-C58E1409-2E53-4E34-A9FA-2FCE8DEFCAE7Q36503299-F824A6E4-1EFE-41A1-AF38-2D95B9BABA25Q37133483-13EE405C-65FB-46CE-8A8D-0C22C704813CQ37370730-7D1C387F-F724-4354-BDFD-4677AB030800Q37432092-E7EBFB79-B01B-4046-9E48-BF2615A4ACEAQ42725944-F669539A-2DA9-4491-BA4F-CAA976FE91D5Q43035123-36E843B3-E593-4FF5-B87A-D2AE21384B41Q43039469-E0800689-F93A-45A7-AECB-72402DBCA47DQ43040750-283B8A3F-FE60-452E-BEDA-0E5F75B00F65Q43040863-8D9715FC-0EB6-4966-AA54-B2AD89C5E37DQ43047734-4D591FA4-5B3D-4AC4-A186-972C3F606B13Q58725798-95A1BC38-435D-45D0-99BA-3DA34FC0E19C
P2860
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@ast
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@en
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@nl
type
label
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@ast
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@en
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@nl
prefLabel
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@ast
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@en
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@nl
P2093
P2860
P3181
P356
P1433
P1476
Liver fibrosis is not associat ...... ients with chronic hepatitis C
@en
P2093
D Cazals-Hatem
M Martinot
M-C Guimont
P2860
P304
P3181
P356
10.1136/GUT.52.11.1638
P407
P577
2003-11-01T00:00:00Z